Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

BNTCBenitec Biopharma Inc.

Nasdaq · CIK 0001808898
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts193

Identity from submissions API

NameBenitec Biopharma Inc.
CIK0001808898
TickersBNTC
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(510) 780-0819
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
3940 TRUST WAY
HAYWARD
CA
94545
CA
Mailing address
3940 TRUST WAY
HAYWARD
CA
94545
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

336 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-13 10-Q 10-Q 0001193125-26-459383 001-39267 261549136 34 6900758 1 1
2026-11-13 8-K 8-K 2.02,5.03,9.01 0001193125-26-459339 001-39267 261549076 34 378706 1 1
2026-10-28 8-K 8-K 7.01,9.01 0001193125-26-435159 001-39267 261492495 34 214436 1 1
2026-10-20 DEFA14A DEFA14A 0001193125-26-426741 001-39267 261473032 34 6454216
2026-10-20 DEF 14A DEF 14A 0001193125-26-426733 001-39267 261473003 34 11331752 1 1
2026-10-05 8-K 8-K 7.01,9.01 0001193125-26-413177 001-39267 261438829 34 192008 1 1
2026-09-30 8-K 8-K 4.01 0001193125-26-409052 001-39267 261427241 34 141986 1 1
2026-09-24 8-K 8-K 4.01,9.01 0001193125-26-401110 001-39267 261405170 34 163042 1 1
2026-09-21 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003021 333-298927 261395155 33 1696
2026-09-14 S-3 S-3 0001193125-26-390758 333-298927 261378220 33 793192 1 1
2026-09-14 10-K 10-K 0001193125-26-390570 001-39267 261377424 34 11391958 1 1
2026-09-14 8-K 8-K 2.02,9.01 0001193125-26-390539 001-39267 261377340 34 405719 1 1
2026-06-30 4 4 0001193125-26-290586 4645
2026-05-29 8-K 8-K 5.02 0001193125-26-248289 001-39267 261044480 34 145746 1 1
2026-05-28 4 4 0001193125-26-245918 6144
2026-05-28 3 3 0001193125-26-245915 2966
2026-05-14 10-Q 10-Q 0001193125-26-222885 001-39267 26975953 34 7500799 1 1
2026-05-14 8-K 8-K 2.02,9.01 0001193125-26-222879 001-39267 26975948 34 458191 1 1
2026-04-03 UPLOAD filename1.pdf 0000000000-26-003380 001-39267 39477
2026-03-20 CORRESP filename1.htm 0001193125-26-117627 18780
2026-03-20 10-K/A 10-K/A 0001193125-26-117604 001-39267 26778192 34 11449047 1 1
2026-02-24 UPLOAD filename1.pdf 0000000000-26-001911 001-39267 42129
2026-02-12 8-K 8-K 2.02,9.01 0001193125-26-047742 001-39267 26623511 34 798128 1 1
2026-02-12 10-Q 10-Q 0001193125-26-047737 001-39267 26623508 34 7507148 1 1
2026-02-11 424B3 424B3 0001193125-26-044984 333-293077 26617447 33 166628
2026-02-10 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000516 333-293077 26618206 33 1695
2026-02-06 CORRESP filename1.htm 0001193125-26-041308 6165
2026-02-06 UPLOAD filename1.pdf 0000000000-26-001290 333-293077 40001
2026-01-30 S-3 S-3 0001193125-26-031753 333-293077 26583290 33 365064 1 1
2026-01-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000038777-26-000024 005-91726 26576018 34 21732
2026-01-26 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-26-000082 5081
2025-12-29 4 xslF345X05/form4.xml 0000899140-25-001479 37577
2025-12-22 4 xslF345X05/form4.xml 0000899140-25-001459 38621
2025-12-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000332 005-91726 251555151 34 11036
2025-12-03 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001346824-25-000066 005-91726 251546758 34 18637
2025-12-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-25-000851 5079
2025-12-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-25-000850 5885
2025-12-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-25-000849 5088
2025-12-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-25-000848 5096
2025-12-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-25-000847 5045
2025-12-02 8-K 8-K 5.07 0001193125-25-305475 001-39267 251544247 34 168685 1 1
2025-11-20 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-25-000813 5109
2025-11-20 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-25-000812 5160
2025-11-20 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-25-000811 5154
2025-11-14 8-K 8-K 2.02,9.01 0001193125-25-283351 001-39267 251488395 34 218746 1 1
2025-11-14 10-Q 10-Q 0001193125-25-283274 001-39267 251488027 34 6880608 1 1
2025-11-12 DEFA14A DEFA14A 0001193125-25-275653 001-39267 251468255 34 15342
2025-11-10 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000899140-25-001257 005-91726 251468123 34 104948
2025-11-10 4 xslF345X05/form4.xml 0000899140-25-001256 27679
2025-11-07 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-25-000718 5108
2025-11-07 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-25-000717 2858
2025-11-07 8-K 8-K 1.01,8.01,9.01 0001193125-25-270490 001-39267 251460195 34 712714 1 1
2025-11-07 424B5 424B5 0001193125-25-270487 333-290455 251460186 33 606221
2025-11-05 424B5 424B5 0001193125-25-267262 333-290455 251455159 33 651511
2025-11-04 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000038777-25-000219 005-91726 251447324 34 22419
2025-11-03 8-K 8-K 5.02,7.01,8.01,9.01 0001193125-25-261665 001-39267 251442096 34 17423141 1 1
2025-10-14 DEFA14A DEFA14A 0001193125-25-239136 001-39267 251392483 34 471177
2025-10-14 DEF 14A DEF 14A 0001193125-25-239131 001-39267 251392471 34 1270362 1 1
2025-09-29 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003153 333-290455 251358030 33 1696
2025-09-26 CORRESP filename1.htm 0001193125-25-220122 20595
2025-09-25 UPLOAD filename1.pdf 0000000000-25-010472 333-290455 39951
2025-09-22 S-3 S-3 0001193125-25-211549 333-290455 251330894 33 839961 1 1
2025-09-22 8-K 8-K 2.02,9.01 0001193125-25-211462 001-39267 251330661 34 420572 1 1
2025-09-22 10-K 10-K 0001193125-25-211361 001-39267 251330349 34 14101774 1 1
2025-09-12 8-K 8-K 4.02 0000950170-25-114530 001-39267 251311628 34 153787 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000251 005-91726 251216350 34 10561
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000247 005-91726 251216012 34 10564
2025-07-09 8-K 8-K 7.01,9.01 0001193125-25-157095 001-39267 251113777 34 152496 1 1
2025-06-02 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001810 333-287566 251017063 33 1696
2025-06-02 424B3 424B3 0001193125-25-133423 333-287566 251015981 33 205581
2025-05-29 CORRESP filename1.htm 0001193125-25-130616 6348
2025-05-29 UPLOAD filename1.pdf 0000000000-25-005638 333-287566 39987
2025-05-23 S-3 S-3 0001193125-25-125878 333-287566 25982944 33 253465
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-049523 005-91726 25954425 34 10899
2025-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000173 005-91726 25944058 34 10494
2025-05-14 8-K 8-K 2.02,9.01 0001193125-25-119402 001-39267 25942695 34 233923 1 1
2025-05-14 10-Q 10-Q 0001193125-25-119383 001-39267 25942617 34 8476094 1 1
2025-05-09 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000038777-25-000082 005-91726 25929386 34 22418
2025-04-02 4 xslF345X05/form4.xml 0000899140-25-000486 34350
2025-03-28 8-K 8-K 8.01 0001193125-25-067232 001-39267 25787683 34 141562 1 1
2025-03-28 4 xslF345X05/form4.xml 0000899140-25-000479 27767
2025-03-28 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000899140-25-000478 005-91726 25787238 34 15874
2025-03-27 8-K 8-K 1.01,9.01 0001193125-25-065613 001-39267 25780424 34 234717 1 1
2025-03-26 424B5 424B5 0001193125-25-063610 333-282957 25770698 33 529335
2025-03-26 8-K 8-K 1.01,8.01,9.01 0001193125-25-063235 001-39267 25770250 34 719414 1 1
2025-03-20 8-K 8-K 8.01 0001193125-25-059398 001-39267 25757829 34 172652 1 1
2025-03-19 8-K 8-K 7.01,9.01 0001193125-25-057153 001-39267 25750858 34 189786 1 1
2025-03-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-005393 6031
2025-03-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-004077 6289
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000094 005-91726 25625799 34 10574
2025-02-14 8-K 8-K 2.02,9.01 0001193125-25-026659 001-39267 25623413 34 246021 1 1
2025-02-14 10-Q FORM 10-Q 0001193125-25-026631 001-39267 25623261 34 8306244 1 1
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-012950 005-91726 25620464 34 7842
2025-01-27 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000038777-25-000005 005-91726 25556929 34 26568
2025-01-03 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-000257 14030
2024-12-31 8-K/A 8-K/A 5.02 0001193125-24-287065 001-39267 241591149 34 146952 1 1
2024-12-26 4 xslF345X05/form4.xml 0000899140-24-001385 34054
2024-12-13 8-K 8-K 5.02 0001193125-24-278529 001-39267 241548575 34 145200 1 1
2024-12-11 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-020503 5892
2024-12-11 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-020470 5068
2024-12-11 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-020468 5052
2024-12-11 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-020466 5095
2024-12-11 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-020464 5135
2024-12-11 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-020462 5121
2024-12-10 8-K 8-K 3.03,5.03,9.01 0001193125-24-274395 001-39267 241539243 34 160007 1 1
2024-12-06 8-K 8-K 5.07 0001193125-24-272533 001-39267 241533062 34 152198 1 1
2024-12-06 SC 13G/A Benitec112924.txt 0001274173-24-000279 005-91726 241531744 34 13524
2024-12-05 4 xslF345X05/form4.xml 0000899140-24-001318 27563
2024-11-21 4 xslF345X05/form4.xml 0000899140-24-001299 33650
2024-11-18 SC 13D/A SCHEDULE 13D/A, AMENDMENT #2 0000899140-24-001285 005-91726 241471977 34 79699
2024-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-24-119174 005-91726 241463810 34 10695
2024-11-14 8-K 8-K 2.02,9.01 0001193125-24-258694 001-39267 241463464 34 243976 1 1
2024-11-14 DEFA14A DEFA14A 0001193125-24-258690 001-39267 241463418 34 24878
2024-11-14 10-Q FORM 10-Q 0001193125-24-258672 001-39267 241463234 34 6747238 1 1
2024-11-14 8-K 8-K 5.02 0001193125-24-258668 001-39267 241463179 34 140268 1 1
2024-11-14 SC 13G/A JANUS AMENDMENT 0001274173-24-000117 005-91726 241459997 34 12971
2024-11-13 SC 13G/A SC 13G/A 0001104659-24-117720 005-91726 241454557 34 53439
2024-11-12 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-11-12 16:30:00 9999999995-24-003464 333-282957 241450894 33 1703
2024-11-12 CORRESP filename1.htm 0001193125-24-255599 6229
2024-11-08 UPLOAD filename1.pdf 0000000000-24-012497 333-282957 39987
2024-11-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000038777-24-000179 005-91726 241434261 34 26683
2024-11-06 SC 13G/A JANUS OWNS OVER 10 0001274173-24-000083 005-91726 241430602 34 13349
2024-11-01 S-3 S-3 0001193125-24-249919 333-282957 241419905 33 704937
2024-10-25 SC 13G/A JANUS OWNS OVER 10 0001274173-24-000082 005-91726 241396310 34 10979
2024-10-22 DEF 14A DEF 14A 0001193125-24-241155 001-39267 241387936 34 551184
2024-10-22 DEFA14A DEFA14A 0001193125-24-241156 001-39267 241387148 34 605021
2024-10-15 8-K 8-K 7.01,9.01 0001193125-24-237227 001-39267 241369386 34 176190 1 1
2024-10-15 424B5 424B5 0001193125-24-237145 333-277310 241369001 33 379106
2024-10-11 424B5 424B5 0001193125-24-236800 333-277310 241368214 33 368423
2024-10-11 PRE 14A PRE 14A 0001193125-24-236694 001-39267 241368065 34 550836
2024-10-11 8-K 8-K 1.01,9.01 0001193125-24-236782 001-39267 241368053 34 449830 1 1
2024-10-08 8-K 8-K 8.01,9.01 0001193125-24-234458 001-39267 241360776 34 165281 1 1
2024-10-01 S-8 S-8 0001193125-24-230255 333-282451 241344003 33 69733
2024-09-30 SC 13D/A SCHEDULE 13D/A, AMENDMENT #1 0000899140-24-001043 005-91726 241340452 34 100654
2024-09-30 4 xslF345X05/form4.xml 0000899140-24-001042 48209
2024-09-26 8-K 8-K 2.02,9.01 0001193125-24-226999 001-39267 241329511 34 250083 1 1
2024-09-26 10-K 10-K 0001193125-24-226968 001-39267 241329407 34 11201672 1 1
2024-09-05 8-K 8-K 5.02,5.07,9.01 0001193125-24-213348 001-39267 241279369 34 152522 1 1
2024-07-29 DEF 14A DEF 14A 0001193125-24-187599 001-39267 241152797 34 964165
2024-07-19 PRE 14A PRE 14A 0001193125-24-181702 001-39267 241128356 34 1030462
2024-07-15 8-K 8-K 7.01,9.01 0001193125-24-179108 001-39267 241118051 34 375853 1 1
2024-07-08 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-013470 2856
2024-07-01 8-K 8-K 5.02,9.01 0001193125-24-173338 001-39267 241091062 34 177996 1 1
2024-05-29 424B3 424B3 0001193125-24-149218 333-279439 24998871 33 258461
2024-05-28 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-05-28 16:00:00 9999999995-24-001662 333-279439 24993878 33 1702
2024-05-23 CORRESP filename1.htm 0001193125-24-146220 6342
2024-05-22 UPLOAD filename1.pdf 0000000000-24-005951 333-279439 40204
2024-05-16 S-1 S-1 0001193125-24-139625 333-279439 24953198 33 375753
2024-05-13 8-K 8-K 2.02,9.01 0001193125-24-136730 001-39267 24936962 34 333871 1 1
2024-05-13 10-Q FORM 10-Q 0001193125-24-136727 001-39267 24936945 34 5706950 1 1
2024-05-02 3 xslF345X02/form3.xml 0000899140-24-000517 38830
2024-04-29 SC 13D SCHEDULE 13D 0000899140-24-000506 005-91726 24890688 34 127352
2024-04-29 SC 13G SC 13G 0001140361-24-022952 005-91726 24890569 34 55606
2024-04-29 SC 13G SC 13G 0001104659-24-053660 005-91726 24888238 34 64394
2024-04-25 D xslFormDX01/primary_doc.xml 06b 0001012975-24-000183 021-511623 24876402 33 10935
2024-04-19 8-K 8-K 1.01,3.02,7.01,9.01 0001193125-24-101289 001-39267 24855465 34 755741 1 1
2024-04-18 8-K 8-K 7.01,9.01 0001193125-24-100080 001-39267 24852978 34 27714202 1 1
2024-04-11 SC 13G/A BENITEC BIOPHARMA INC. 0000902664-24-002844 005-91726 24837680 34 99240
2024-03-08 8-K 8-K 5.02 0001193125-24-063667 001-39267 24734588 34 141577 1 1
2024-03-08 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-005970 5145
2024-03-08 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-005969 5134
2024-03-05 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-03-05 16:00:00 9999999995-24-000607 333-277310 24724276 33 1702
2024-03-01 CORRESP filename1.htm 0001193125-24-055978 6034
2024-02-28 UPLOAD filename1.pdf 0000000000-24-002254 333-277310 40230
2024-02-26 DEL AM DEL AM 0001193125-24-045491 333-277310 24673791 33 7042
2024-02-23 S-3 S-3 0001193125-24-044499 333-277310 24671217 33 683371
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-024117 005-91726 24641172 34 137863
2024-02-13 SC 13G/A JHG PLC & JHBIF >5% 0001274173-24-000053 005-91726 24633401 34 13452
2024-02-13 SC 13G/A d10964649_13g-a.htm 0000919574-24-001070 005-91726 24629857 34 146448
2024-02-13 8-K 8-K 2.02,9.01 0001193125-24-032956 001-39267 24622681 34 252519 1 1
2024-02-13 10-Q FORM 10-Q 0001193125-24-032940 001-39267 24622654 34 4980956 1 1
2023-12-26 S-8 S-8 0001193125-23-302272 333-276267 231511162 33 68962
2023-12-11 SC 13G/A beni23a2.htm 0000038777-23-000172 005-91726 231477378 34 228980
2023-12-07 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-022120 5101
2023-12-07 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-022119 5074
2023-12-07 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-022118 5058
2023-12-07 8-K 8-K 5.02,5.07,9.01 0001193125-23-290709 001-39267 231472567 34 155141 1 1
2023-11-30 8-K 8-K 7.01,9.01 0001193125-23-285671 001-39267 231453972 34 161334 1 1
2023-11-13 8-K 8-K 2.02,9.01 0001193125-23-275384 001-39267 231395255 34 235871 1 1
2023-11-13 10-Q FORM 10-Q 0001193125-23-275377 001-39267 231395233 34 6551567 1 1
2023-10-20 DEFA14A DEFA14A 0001193125-23-259962 001-39267 231337448 34 482399
2023-10-20 DEF 14A DEF 14A 0001193125-23-259531 001-39267 231335904 34 1278206 1 1
2023-10-16 8-K 8-K 5.02 0001193125-23-257001 001-39267 231328066 34 140250 1 1
2023-09-28 8-K 8-K 8.01 0001193125-23-245807 001-39267 231290902 34 144300 1 1
2023-09-21 8-K 8-K 2.02,9.01 0001193125-23-239127 001-39267 231267780 34 238864 1 1
2023-09-21 10-K 10-K 0001193125-23-239121 001-39267 231267770 34 9526449 1 1
2023-09-18 8-K 8-K 5.02 0001193125-23-237014 001-39267 231261930 34 139366 1 1
2023-09-11 SC 13G/A beni23a1.htm 0000038777-23-000133 005-91726 231247140 34 228507
2023-08-25 SC 13G BENITEC BIOPHARMA INC. 0000902664-23-004626 005-91726 231208746 34 101357
2023-08-21 SC 13G SC 13G 0001104659-23-093916 005-91726 231189199 34 136345
2023-08-18 SC 13G JHG PLC OWNS 9.9% OF BENITEC 0001274173-23-000086 005-91726 231185727 34 13369
2023-08-18 SC 13G/A SC 13G/A 0001104659-23-093323 005-91726 231184290 34 49730
2023-08-14 4 FORM 4 SUBMISSION 0000899243-23-018119 8019
2023-08-14 4 4 0000950170-23-042536 6837
2023-08-11 8-K 8-K 1.01,8.01,9.01 0001193125-23-210679 001-39267 231163867 34 777850 1 1
2023-08-10 8-K 8-K 3.01 0001193125-23-209112 001-39267 231160238 34 140356 1 1
2023-08-10 424B4 424B4 0001193125-23-209029 333-273177 231159306 33 2329744
2023-08-08 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-08-08 17:30:00 9999999995-23-002308 333-273177 231153186 33 1654
2023-08-07 S-1/A S-1/A 0001193125-23-204498 333-273177 231145726 33 2596560
2023-08-03 CORRESP filename1.htm 0001193125-23-202432 6600
2023-08-03 CORRESP filename1.htm 0001193125-23-202427 5776
2023-08-03 S-1/A S-1/A 0001193125-23-202324 333-273177 231138229 33 2849175
2023-07-31 S-1/A S-1/A 0001193125-23-198629 333-273177 231125158 33 2662216
2023-07-25 8-K 8-K 3.03,5.03,7.01,8.01,9.01 0001193125-23-193295 001-39267 231108003 34 186112 1 1
2023-07-11 UPLOAD filename1.pdf 0000000000-23-007358 40091
2023-07-07 S-1 S-1 0001193125-23-183854 333-273177 231077450 33 2324190
2023-06-26 8-K 8-K 7.01,9.01 0001193125-23-174479 001-39267 231039458 34 159035 1 1
2023-06-15 8-K 8-K 5.02 0001193125-23-167929 001-39267 231017610 34 139998 1 1
2023-06-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-013639 5053
2023-06-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-013634 5064
2023-05-15 8-K 8-K 2.02,9.01 0001193125-23-144217 001-39267 23918531 34 254447 1 1
2023-05-15 10-Q FORM 10-Q 0001193125-23-144211 001-39267 23918501 34 5230916 1 1
2023-04-18 SC 13G/A d10623048_13g-a.htm 0000919574-23-002619 005-91726 23827032 34 116646
2023-03-08 8-K 8-K 3.01 0001193125-23-064582 001-39267 23716560 34 141982 1 1
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021115 005-91726 23624728 34 64014
2023-02-13 SC 13G/A d9927314_13g-a.htm 0000919574-23-001024 005-91726 23616137 34 126059
2023-02-13 8-K 8-K 2.02,9.01 0001193125-23-034348 001-39267 23614805 34 252176 1 1
2023-02-13 10-Q 10-Q 0001193125-23-034339 001-39267 23614797 34 4247767 1 1
2023-02-08 SC 13G/A SCHEDULE 13G/A BNTC SILVERARC 0001816307-23-000004 005-91726 23596277 34 66319
2023-01-23 8-K 8-K 7.01,9.01 0001193125-23-012670 001-39267 23542566 34 162369 1 1
2022-12-19 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2022-12-19 16:15:00 9999999995-22-003586 333-268763 221472768 33 1654
2022-12-15 CORRESP filename1.htm 0001193125-22-305870 5863
2022-12-14 UPLOAD filename1.pdf 0000000000-22-013474 40097
2022-12-13 S-1 S-1 0001193125-22-303006 333-268763 221458290 33 2132204
2022-12-12 8-K 8-K 3.03,5.03,9.01 0001193125-22-302288 001-39267 221456168 34 155656 1 1
2022-12-09 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-023660 5069
2022-12-09 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-023659 5026
2022-12-09 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-023658 5042
2022-12-08 8-K 8-K 5.07,9.01 0001193125-22-301044 001-39267 221452732 34 159886 1 1
2022-11-10 8-K 8-K 2.02,9.01 0001193125-22-281980 001-39267 221375035 34 239879 1 1
2022-11-10 10-Q 10-Q 0001193125-22-281978 001-39267 221375029 34 4118024 1 1
2022-10-25 DEFA14A DEFA14A 0001193125-22-268388 001-39267 221329704 34 1240327
2022-10-25 DEF 14A DEF 14A 0001193125-22-268377 001-39267 221329666 34 557097
2022-10-18 8-K 8-K 5.02 0001193125-22-264446 001-39267 221316063 34 141087 1 1
2022-10-14 PRE 14A PRE 14A 0001193125-22-262970 001-39267 221311589 34 559244
2022-10-11 SC 13G beni22in.htm 0000038777-22-000166 005-91726 221303214 34 227258
2022-10-07 SC 13G/A SC 13G/A 0001104659-22-107022 005-91726 221300029 34 50244
2022-09-23 SC 13G SC 13G 0001104659-22-102534 005-91726 221260955 34 88968
2022-09-16 8-K 8-K 1.01,8.01,9.01 0001193125-22-246077 001-39267 221247037 34 785559 1 1
2022-09-14 424B4 424B4 0001193125-22-244827 333-266417 221243640 33 2284025
2022-09-12 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2022-09-12 17:30:00 9999999995-22-002665 333-266417 221239660 33 1654
2022-09-12 S-1/A S-1/A 0001193125-22-242886 333-266417 221238781 33 2380519
2022-09-09 S-1/A S-1/A 0001193125-22-241222 333-266417 221234897 33 2480733
2022-09-08 CORRESP filename1.htm 0001193125-22-241233 6255
2022-09-08 CORRESP filename1.htm 0001193125-22-241227 6735
2022-09-07 8-K 8-K 3.01 0001193125-22-240014 001-39267 221231367 34 141286 1 1
2022-09-02 10-K 10-K 0001193125-22-237075 001-39267 221223259 34 6921867 1 1
2022-09-02 8-K 8-K 2.02,9.01 0001193125-22-237060 001-39267 221223254 34 239876 1 1
2022-08-11 CORRESP filename1.htm 0001193125-22-218076 6985
2022-08-10 S-1/A S-1/A 0001193125-22-217292 333-266417 221151643 33 155489
2022-08-08 CORRESP filename1.htm 0001193125-22-214694 6873
2022-08-08 CORRESP filename1.htm 0001193125-22-214461 5518
2022-08-08 S-1/A S-1/A 0001193125-22-214263 333-266417 221142736 33 2789447
2022-08-04 UPLOAD filename1.pdf 0000000000-22-008266 40104
2022-07-29 S-1 S-1 0001193125-22-206703 333-266417 221121350 33 2419924
2022-05-16 10-Q FORM 10-Q 0001193125-22-150924 001-39267 22925598 34 5474407 1 1
2022-05-16 8-K 8-K 2.02,9.01 0001193125-22-150922 001-39267 22925581 34 251621 1 1
2022-02-14 10-Q FORM 10-Q 0001193125-22-039683 001-39267 22625496 34 4795999 1 1
2022-02-14 8-K 8-K 2.02,9.01 0001193125-22-039653 001-39267 22625445 34 241900 1 1
2022-02-09 SC 13G schedule13gbntcsilverarc.htm 0001816307-22-000007 005-91726 22611396 34 67961
2022-02-09 SC 13G schedule13gbntcsilverarc.htm 0001816307-22-000005 005-91726 22611389 34 67961
2022-02-09 SC 13G schedule13gbntcsilverarc.htm 0001816307-22-000006 005-91726 22607792 34 67961
2022-02-08 SC 13G/A BNTC 13G/A 0001393825-22-000194 005-91726 22602062 34 54457
2022-01-21 8-K/A 8-K/A 5.07 0001193125-22-014852 001-39267 22546305 34 146736 1 1
2022-01-13 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0001213900-22-001861 005-91726 22528211 34 45964
2021-12-23 S-8 S-8 0001193125-21-366283 333-261874 211517556 33 51485
2021-12-21 8-K 8-K 3.03,5.03,9.01 0001193125-21-363633 001-39267 211509820 34 156853 1 1
2021-12-13 8-K 8-K 5.02,5.07,9.01 0001193125-21-355561 001-39267 211488879 34 170456 1 1
2021-12-10 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-21-012696 5024
2021-12-10 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-21-012695 5067
2021-12-10 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-21-012694 5040
2021-12-09 4 FORM 4 0001104659-21-148207 12803
2021-12-09 3 FORM 3 0001104659-21-148204 3600
2021-11-15 8-K FORM 8-K 2.02,9.01 0001193125-21-329092 001-39267 211406741 34 220307 1 1
2021-11-15 10-Q FORM 10-Q 0001193125-21-328795 001-39267 211406074 34 3951587 1 1
2021-10-22 DEF 14A DEF 14A 0001193125-21-304643 001-39267 211338666 34 1360543
2021-10-12 PRE 14A PRE 14A 0001193125-21-296224 001-39267 211316704 34 1355765
2021-09-20 8-K 8-K 5.02 0001193125-21-276778 001-39267 211262090 34 17393
2021-09-20 8-K 8-K 2.02,9.01 0001193125-21-276763 001-39267 211262079 34 87074
2021-09-20 10-K 10-K 0001193125-21-276758 001-39267 211262074 34 10952917 1 1
2021-05-12 10-Q 10-Q 0001193125-21-159276 001-39267 21916124 34 3828703 1
2021-05-07 SC 13G d8849683.htm 0000919574-21-003288 005-91726 21903570 34 118167
2021-04-29 8-K 8-K 1.01,8.01,9.01 0001193125-21-140764 001-39267 21871854 34 217601
2021-04-29 424B5 424B5 0001193125-21-140732 333-253259 21871731 33 1851716
2021-04-28 SC 13G SC 13G 0001104659-21-056654 005-91726 21865629 34 163530
2021-04-28 FWP FWP 0001193125-21-135023 333-253259 21861129 34 11989
2021-04-27 FWP FWP 0001193125-21-134509 333-253259 21860180 34 11921
2021-04-27 424B5 424B5 0001193125-21-134352 333-253259 21859549 33 1854325
2021-04-14 SC 13G/A SC 13G/A 0001104659-21-050294 005-91726 21826446 34 57457
2021-04-12 SC 13G/A MS AMENDMENT 0000895421-21-000321 005-91726 21821262 34 17600
2021-04-05 SC 13G SC 13G 0001104659-21-046246 005-91726 21803635 34 55031
2021-03-22 SC 13G MS INITIAL 0000895421-21-000297 005-91726 21761759 34 17250
2021-02-26 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-02-26 16:00:00 9999999995-21-000768 333-253259 21693489 33 1653
2021-02-25 CORRESP filename1.htm 0001193125-21-056606 5595
2021-02-24 8-K 8-K 7.01,8.01,9.01 0001193125-21-054896 001-39267 21675007 34 6897129
2021-02-24 UPLOAD filename1.pdf 0000000000-21-002219 40087
2021-02-18 S-3 S-3 0001193125-21-047700 333-253259 21649476 33 587821
2021-02-18 S-8 S-8 0001193125-21-047697 333-253258 21649462 33 86359
2021-02-12 SC 13G/A form13ga.htm 0001493152-21-003634 005-91726 21627161 34 163781
2021-02-09 10-Q 10-Q 0001193125-21-033243 001-39267 21603880 34 3692963 1
2021-02-09 SC 13G BNTC 13G 0001393825-21-000015 005-91726 21602845 34 59145
2021-01-19 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001213900-21-002807 005-91726 21535265 34 60197
2021-01-08 SC 13G/A SABBY 13G-A BNTC 1.08.21 0001535610-21-000071 005-91726 21516075 34 14861
2020-12-15 8-K 8-K 5.02,9.01 0001193125-20-318182 001-39267 201390188 34 94393
2020-12-14 8-K 8-K 5.02,5.07,9.01 0001193125-20-317105 001-39267 201387083 34 129312
2020-12-11 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-20-006261 5060
2020-12-11 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-20-006259 5076
2020-12-11 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-20-006257 5103
2020-12-11 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-20-006255 5064
2020-12-11 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-20-006253 5075
2020-11-13 10-Q 10-Q 0001193125-20-292209 001-39267 201309103 34 3054312 1
2020-11-03 8-K 8-K 4.01,9.01 0001193125-20-284828 001-39267 201284229 34 23595
2020-10-27 8-K 8-K 5.02 0001193125-20-278391 001-39267 201264189 34 17531
2020-10-22 DEF 14A DEF 14A 0001193125-20-274452 001-39267 201255290 34 1329188
2020-10-13 SC 13G SCHEDULE 13G 0001213900-20-030943 005-91726 201234465 34 33544
2020-10-07 SC 13G form13g.htm 0001493152-20-019063 005-91726 201228040 34 190314
2020-10-06 8-K 8-K 1.01,8.01,9.01 0001193125-20-264805 001-39267 201227223 34 44999
2020-10-06 424B4 424B4 0001193125-20-264192 333-246314 201225253 33 1023690
2020-10-02 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-10-02 09:00:00 9999999995-20-002724 333-246314 201222181 33 1688
2020-10-01 CORRESP filename1.htm 0001193125-20-260854 10297
2020-10-01 CORRESP filename1.htm 0001193125-20-260851 5890
2020-10-01 S-1/A S-1/A 0001193125-20-260736 333-246314 201214675 33 1376679
2020-09-23 8-K 8-K 2.02,9.01 0001193125-20-252398 001-39267 201192630 34 81186
2020-09-23 10-K FORM 10-K 0001193125-20-252381 001-39267 201192525 34 7434516 1
2020-08-24 UPLOAD filename1.pdf 0000000000-20-007885 40188
2020-08-19 8-K/A 8-K/A 4.01,9.01 0001193125-20-224708 001-39267 201117249 34 25310
2020-08-18 8-K 8-K 8.01 0001193125-20-222612 001-39267 201111287 34 17246
2020-08-14 S-1 FORM S-1 0001193125-20-220358 333-246314 201105160 33 3996382
2020-06-05 8-K 8-K 4.01,9.01 0001193125-20-162330 001-39267 20947406 34 26580
2020-04-27 3 FORM 3 SUBMISSION 0000899243-20-011340 7339
2020-04-27 3 FORM 3 SUBMISSION 0000899243-20-011330 5996
2020-04-27 3 FORM 3 SUBMISSION 0000899243-20-011328 7125
2020-04-27 3 FORM 3 SUBMISSION 0000899243-20-011325 3477
2020-04-27 3 FORM 3 SUBMISSION 0000899243-20-011324 6388
2020-04-27 3 FORM 3 SUBMISSION 0000899243-20-011323 7051
2020-04-15 8-K12B 8-K12B 3.01,3.02,3.03,5.01,5.02,5.03,5.05,8.01,9.01 0001564590-20-016820 001-39267 20792758 34 825830

Latest XBRL company facts

One latest value per concept from companyfacts (193 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 36.12M 2026-11-09 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
dei EntityListingParValuePerShare Entity Listing, Par Value Per Share USD/shares 0 2019-07-01 2020-06-30 2020 FY 10-K 2020-09-23 0001193125-20-252381
dei EntityPublicFloat Entity Public Float USD 143.06M 2025-12-31 2026 FY 10-K 2026-09-14 0001193125-26-390570
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 5.52M 2025-07-01 2026-06-30 DEF 14A 2026-10-20 0001193125-26-426733
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 4.94M 2025-07-01 2026-06-30 DEF 14A 2026-10-20 0001193125-26-426733
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 9.54M 2025-07-01 2026-06-30 DEF 14A 2026-10-20 0001193125-26-426733
ecd PeoTotalCompAmt PeoTotalCompAmt USD 6.52M 2025-07-01 2026-06-30 DEF 14A 2026-10-20 0001193125-26-426733
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 330.18 2025-07-01 2026-06-30 DEF 14A 2026-10-20 0001193125-26-426733
ffd NetFeeAmt NetFeeAmt USD 27,620 2026-09-10 S-3 2026-09-14 0001193125-26-390758
ffd TtlFeeAmt TtlFeeAmt USD 27,620 2026-09-10 S-3 2026-09-14 0001193125-26-390758
ffd TtlOfferingAmt TtlOfferingAmt USD 200.00M 2026-09-10 S-3 2026-09-14 0001193125-26-390758
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-09-10 S-3 2026-09-14 0001193125-26-390758
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-09-10 S-3 2026-09-14 0001193125-26-390758
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 0 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 7.96M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 1.02M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 112,000 2021-09-30 2022 Q1 10-Q 2021-11-15 0001193125-21-328795
us-gaap AccruedBonusesCurrentAndNoncurrent Accrued Bonuses USD 26,000 2023-09-30 2024 Q1 10-Q 2023-11-13 0001193125-23-275377
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 0 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.33M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -947,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 457.24M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 5.51M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 6.27M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 5.51M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 11.98M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap Assets Assets USD 179.10M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap AssetsCurrent Assets, Current USD 178.10M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Assets USD 200,000 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap Cash Cash USD 98.60M 2026-03-31 2026 Q3 10-Q 2026-05-14 0001193125-26-222885
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 176.37M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 2.19M 2020-07-01 2021-03-31 2021 Q3 10-Q 2021-05-12 0001193125-21-159276
us-gaap CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 9.47M 2020-07-01 2021-06-30 2021 FY 10-K 2021-09-20 0001193125-21-276758
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 176.48M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -3.60M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 11.22 2022-09-15 2026 Q3 10-Q 2026-05-14 0001193125-26-222885
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 2.58M 2024-04-22 2025 FY 10-K/A 2026-03-20 0001193125-26-117604
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 19.55M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 35.76M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 160.00M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 34.89M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 34.89M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap CommonStockValue Common Stock, Value, Issued USD 4,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -12.91M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap ContractWithCustomerAssetNetCurrent Contract with Customer, Asset, after Allowance for Credit Loss, Current USD 0 2020-06-30 2020 FY 10-K 2020-09-23 0001193125-20-252381
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 681,000 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 250,000 2019-06-30 2020 FY 10-K 2020-09-23 0001193125-20-252381
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 192,000 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 30.82M 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 254,000 2021-06-30 2021 FY 10-K 2021-09-20 0001193125-21-276758
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 23.50M 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 129,000 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 5,000 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 1.30M 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 30.14M 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 146,000 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap DeferredTaxLiabilitiesPrepaidExpenses Deferred Tax Liabilities, Prepaid Expenses USD 329,000 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 0 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains Deferred Tax Liabilities, Unrealized Currency Transaction Gains USD 206,000 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap DepositAssets Deposit Assets USD 55,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap Depreciation Depreciation USD 19,000 2023-07-01 2023-09-30 2024 Q1 10-Q 2023-11-13 0001193125-23-275377
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 17,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap DueFromBanks Due from Banks USD 176.37M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.26 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.61 2021-07-01 2022-03-31 2022 Q3 10-Q 2022-05-16 0001193125-22-150924
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.26 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.112 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap EffectiveIncomeTaxRateReconciliationDeductionsOther Effective Income Tax Rate Reconciliation, Deduction, Other, Percent pure 0.086 2024-07-01 2025-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.001 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.001 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure 0.157 2018-07-01 2019-06-30 2020 FY 10-K 2020-09-23 0001193125-20-252381
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.014 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.005 2024-07-01 2025-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.069 2018-07-01 2019-06-30 2020 FY 10-K 2020-09-23 0001193125-20-252381
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD -95,000 2021-07-01 2022-03-31 2022 Q3 10-Q 2022-05-16 0001193125-22-150924
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 19,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 608,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 20.50M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense Share-based Payment Arrangement, Expense, Tax Benefit USD 34,000 2022-07-01 2023-03-31 2024 FY 10-K 2024-09-26 0001193125-24-226968
us-gaap ForeignCurrencyExchangeRateTranslation1 Foreign Currency Exchange Rate, Translation pure 0.007 2025-06-30 2025 FY 10-K/A 2026-03-20 0001193125-26-117604
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -23,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -1,000 2019-07-01 2020-06-30 2021 FY 10-K 2021-09-20 0001193125-21-276758
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 5.86M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap GrantsReceivableCurrent Grants Receivable, Current USD 636,000 2019-06-30 2020 FY 10-K 2020-09-23 0001193125-20-252381
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -45.34M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -211,000 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 5.10M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -52,000 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -9.56M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 50,000 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 638,000 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap IncreaseDecreaseInAccountsAndOtherReceivables Increase (Decrease) in Accounts and Other Receivables USD -5,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD 56,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -388,000 2022-07-01 2022-12-31 2023 Q2 10-Q 2023-02-13 0001193125-23-034339
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 173,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 1.58M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.06 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 666,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two USD 16,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months USD 518,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 132,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 62,000 2023-03-31 2023 Q3 10-Q 2023-05-15 0001193125-23-144211
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 291,000 2024-03-31 2024 Q3 10-Q 2024-05-13 0001193125-24-136727
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 267,000 2025-03-31 2025 Q3 10-Q 2025-05-14 0001193125-25-119383
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 24,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap Liabilities Liabilities USD 9.45M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 179.10M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap LiabilitiesCurrent Liabilities, Current USD 9.08M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 0 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 0 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -3.62M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -12.93M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -45.55M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 1.55M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap OperatingExpenses Operating Expenses USD 14.48M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -14.48M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 100,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 642,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 507,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 135,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap OperatingLeasePayments Operating Lease, Payments USD 120,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 585,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 108,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 156.00M 2020-07-01 2021-03-31 2021 Q3 10-Q 2021-05-12 0001193125-21-159276
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 179,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap OtherAssets Other Assets USD 1.87M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap OtherAssetsCurrent Other Assets, Current USD 1.62M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 244,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax USD 16,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 16,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -1,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 21,000 2020-12-31 2021 Q2 10-Q 2021-02-09 0001193125-21-033243
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 6.27M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 105,000 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-03-31 2026 Q3 10-Q 2026-05-14 0001193125-26-222885
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 1.62M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap PrepaidExpenseAndOtherAssetsNoncurrent Prepaid Expense and Other Assets, Noncurrent USD 244,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 1.16M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 27.90M 2023-08-11 2026 Q3 10-Q 2026-05-14 0001193125-26-222885
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 104.50M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 67,000 2024-07-01 2025-06-30 2025 FY 10-K/A 2026-03-20 0001193125-26-117604
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 1,000 2019-07-01 2020-06-30 2021 FY 10-K 2021-09-20 0001193125-21-276758
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 1.44M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 110,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 8.62M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 176.48M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 114,000 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -286.65M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 0 2024-07-01 2024-12-31 2024 Q2 10-Q 2025-02-14 0001193125-25-026631
us-gaap RevenueNotFromContractWithCustomerOther Revenue Not from Contract with Customer, Other USD 5,000 2019-07-01 2020-06-30 2021 FY 10-K 2021-09-20 0001193125-21-276758
us-gaap Revenues Revenues USD 0 2025-07-01 2026-03-31 2026 Q3 10-Q 2026-05-14 0001193125-26-222885
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2022-07-01 2023-06-30 2023 FY 10-K 2023-09-21 0001193125-23-239121
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 5.75M 2024-04-22 2026 Q3 10-Q 2026-05-14 0001193125-26-222885
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 4.8 2024-04-22 2026 Q3 10-Q 2026-05-14 0001193125-26-222885
us-gaap SecurityDeposit Security Deposit USD 15,000 2022-03-31 2022 Q3 10-Q 2022-05-16 0001193125-22-150924
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 5.51M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.142 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 1.274 2020-07-01 2021-06-30 2022 FY 10-K 2022-09-02 0001193125-22-237075
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 1.156 2022-07-01 2023-06-30 2023 FY 10-K 2023-09-21 0001193125-23-239121
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.038 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.006 2020-07-01 2021-06-30 2022 FY 10-K 2022-09-02 0001193125-22-237075
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.04 2022-07-01 2023-06-30 2023 FY 10-K 2023-09-21 0001193125-23-239121
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 12.07 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit USD 0 2022-06-30 2022 FY 10-K 2022-09-02 0001193125-22-237075
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 169.65M 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 625,000 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 34,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap TimeDepositsAtCarryingValue Time Deposits, at Carrying Value USD 4.57M 2020-06-30 2021 FY 10-K 2021-09-20 0001193125-21-276758
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 0 2024-07-01 2025-06-30 2025 FY 10-K/A 2026-03-20 0001193125-26-117604
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2022-06-30 2022 FY 10-K 2022-09-02 0001193125-22-237075
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2023-06-30 2023 FY 10-K 2023-09-21 0001193125-23-239121
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 5.10M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-14 0001193125-26-390570
us-gaap WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount USD 0 2024-07-01 2025-06-30 2025 FY 10-K/A 2026-03-20 0001193125-26-117604
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 49.49M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 8.17M 2021-07-01 2022-03-31 2022 Q3 10-Q 2022-05-16 0001193125-22-150924
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 49.49M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-13 0001193125-26-459383

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →